Therefore, we propose a new mechanism by which FOXO3 induces apoptosis in ovarian cancer cells in response to auranofin treatment through upregulation of Bax and Bim and downregulation of Bcl-2 in a p53-independent manner (Fig. 8). The gene discussed is BCL2L11; the disease is ovarian carcinoma.